Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
biosimilars." -- Melissa Bartlett, Senior Vice President, Health Policy, The ERISA Industry Committee (ERIC) “The bipartisan Expedited Access